PRESS RELEASE published on 05/18/2026 at 17:47, 1 month 7 days ago Key Figures 15.05.2026 HBM Healthcare Investments AG reports key financial figures for May 15, 2026. NAV at 283.73 CHF with slight decrease and total net assets at 1,874 million CHF Financial Figures HBM Healthcare Investments AG NAV Total Net Assets May 15 2026
BRIEF published on 05/13/2026 at 06:45, 1 month 13 days ago HBM Healthcare Investments annonce un bénéfice de 272 millions de francs suisses Résultats Financiers Proposition De Dividende Performance Du Portefeuille HBM Healthcare Secteur De La Biotechnologie
BRIEF published on 05/13/2026 at 06:45, 1 month 13 days ago HBM Healthcare Investments Reports CHF 272 Million Profit Financial Results Portfolio Performance Dividend Proposal Biotechnology Sector HBM Healthcare
PRESS RELEASE published on 05/13/2026 at 06:40, 1 month 13 days ago HBM Healthcare Investments posts profit of CHF 272 million in its 25th financial year HBM Healthcare Investments posts CHF 272 million profit in 25th financial year. NAV up 17.2%, share price up 28.5%. Positive market outlook with proposed dividend of CHF 9.00 HBM Healthcare Investments Dividend Positive Outlook NAV Profit
BRIEF published on 05/01/2026 at 17:52, 1 month 24 days ago HBM Healthcare Investments AG publie ses chiffres clés d'avril 2026 Performance Financière HBM Healthcare Croissance De L'ANR Hausse Du Cours De L'action Chiffres De 2026
BRIEF published on 05/01/2026 at 17:52, 1 month 24 days ago HBM Healthcare Investments AG Reports April 2026 Key Figures Financial Performance Share Price Increase NAV Growth HBM Healthcare 2026 Figures
PRESS RELEASE published on 05/01/2026 at 17:47, 1 month 24 days ago Key Figures 30.04.2026 HBM Healthcare Investments AG reports key figures as of 30.04.2026, with NAV at 285.12 CHF and share price at 235.00 CHF. Performance percentages are also provided Performance HBM Healthcare Investments AG Key Figures CHF 30.04.2026
BRIEF published on 04/16/2026 at 17:51, 2 months 9 days ago HBM Healthcare Investments Reports April 2026 Performance Financial Performance Net Asset Value Share Price Investment Risks HBM Healthcare
BRIEF published on 04/16/2026 at 17:51, 2 months 9 days ago HBM Healthcare Investments publie ses résultats d'avril 2026 Performance Financière Valeur Nette D'actif Prix De L'action Risques D'investissement HBM Healthcare
PRESS RELEASE published on 04/16/2026 at 17:46, 2 months 9 days ago Key Figures 15.04.2026 HBM Healthcare Investments AG reports key figures for April 15, 2026, showing a positive performance in CHF. Monthly and year-to-date metrics are provided Financial Performance Investment Switzerland HBM Healthcare Investments AG Key Figures
Published on 06/26/2026 at 01:40, 7 hours 44 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 9 hours 54 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 10 hours 54 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 11 hours 52 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 17 hours 54 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 09:05, 18 minutes ago Avinox Wins Eurobike 2026 Award with its Smart Heart Rate Control System
Published on 06/26/2026 at 09:02, 21 minutes ago Kirchhoff Consult and DSW publish 2026 forecast report study: Number of transparent forecast reports in the DAX 40 rises
Published on 06/26/2026 at 09:00, 23 minutes ago Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 06/26/2026 at 09:00, 23 minutes ago Partners Group launches B Residences strategy to build flagship Breitling-branded luxury condominium tower in Miami
Published on 06/26/2026 at 07:00, 2 hours 24 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 2 hours 24 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 14 hours 38 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 14 hours 54 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 15 hours 34 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
